Frontiers in Pharmacology · 2010 · 66 citations · 58 references
MedicineCancer BiologyOncologyApoptosisCarcinogenesisMolecular OncologyApoptosis In CancerCancer Cell SignalingOncogenic Signaling Pathways5-Lipoxygenase InhibitionApoptosis Signaling In CancerApoptotic Signaling In CancerApoptotic Signaling PathwaysCancer Cell ApoptosisCancer Cell Proliferation InhibitionColorectal Carcinogenesis PathophysiologyIntrinsic Apoptosis Pathway
Leukotrienes constitute a group of bioactive lipids generated by the 5-lipoxygenase (5-LO) pathway. An increasing body of evidence supports an acute role for 5-LO products already during the earliest stages of pancreatic, prostate, and colorectal carcinogenesis. Several pieces of experimental data form the basis for this hypothesis and suggest a correlation between 5-LO expression and tumor cell viability. First, several independent studies documented an overexpression of 5-LO in primary tumor cells as well as in established cancer cell lines. Second, addition of 5-LO products to cultured tumor cells also led to increased cell proliferation and activation of anti-apoptotic signaling pathways. 5-LO antisense technology approaches demonstrated impaired tumor cell growth due to reduction of 5-LO expression. Lastly, pharmacological inhibition of 5-LO potently suppressed tumor cell growth by inducing cell cycle arrest and triggering cell death via the intrinsic apoptotic pathway. However, the documented strong cytotoxic off-target effects of 5-LO inhibitors, in combination with the relatively high concentrations of 5-LO products needed to achieve mitogenic effects in cell culture assays, raise concern over the assignment of the cause, and question the relationship between 5-LO products and tumorigenesis.
58
Lipid mediator class switching during acute inflammation: signals in resolution
Bruce D. Levy, Clary B. Clish, Birgitta Schmidt et al. · Nature Immunology · 2001 · 1.4K citations
5-lipoxygenase inhibitory activity of zileuton.
G W Carter, Patrick Young, Daniel H. Albert et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 420 citations
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
Yaoyu Chen, Yiguo Hu, Haojian Zhang et al. · Nature Genetics · 2009 · 289 citations · Full text